Professional Reference articles are designed for health professionals to use. They are written by UK doctors and based on research evidence, UK and European Guidelines. You may find the Cold Sores article more useful, or one of our other health articles.
Treatment of almost all medical conditions has been affected by the COVID-19 pandemic. NICE has issued rapid update guidelines in relation to many of these. This guidance is changing frequently. Please visit https://www.nice.org.uk/covid-19 to see if there is temporary guidance issued by NICE in relation to the management of this condition, which may vary from the information given below.
Synonyms: oral herpes labialis, cold sore
Of the herpes viruses, herpes simplex virus type 1 (HSV-1) is usually the cause of oral infection. After primary infection, HSV-1 becomes latent, usually in the dorsal root ganglia of the trigeminal nerve. Rarely, herpes simplex virus type 2 (HSV-2) may cause primary infection of the oral cavity, typically in association with orogenital sex; however, recurrent oral HSV-2 disease is rare.
- About 1% of primary care consultations are for cold sores.
- 56-85% of people have serological evidence of HSV-1 infection by early adulthood. Prevalence depends on their resident country.
- 20-40% of young adults who are seropositive for HSV-1 have recurrent cold sores.
- Recurrences occur typically between two and six times a year.
- A study of the global burden of HSV-1 reported an estimated worldwide prevalence of HSV-1 infection among those aged 0-49 years in 2012 of 67%. Prevalence increased with age and was high across all regions but highest in Africa (87% overall prevalence) and lowest in the Americas (40-50%).
- Transmission is due to viral shedding into saliva and can occur by direct contact with saliva (eg, kissing). Viral shedding into saliva may occur during asymptomatic infection but it is thought that the risk of infection is much smaller than during symptomatic infection.
- Viral shedding can occur up to 60 hours after the onset of symptoms.
- Factors that may trigger a recurrence of oral herpes simplex include immunosuppression (eg, corticosteroids), upper respiratory tract infections, fatigue, emotional stress, physical trauma, exposure to sun (ultraviolet light), trauma and menstruation.
- Obesity may increase susceptibility to HSV-1 infection.
Infection with HSV can cause pain and blistering within the mouth (gingivostomatitis or recurrent oral ulceration) or on or around the lips (cold sores or herpes labialis).
- This occurs most often in infancy or childhood. It may or may not be symptomatic.
- Gingivostomatitis is the most common presentation in young children. It presents with vesicles and ulcers on the tongue, lips, gums, buccal mucosa and hard and soft palates. Pain, inability to swallow, drooling and dehydration are common. There may be associated fever, cervical lymphadenopathy, halitosis, lethargy, irritability and loss of appetite.
- Pharyngitis is a more common presentation in adolescents, with lesions in the throat associated with viral symptoms similar to those of infectious mononucleosis.
- Herpetic whitlow may occasionally occur via spread to the fingers.
- Cold sore lesions are the most common form of recurrent disease. They tend to occur in the same location, be unilateral and recur two or three times a year on average.
- Prodromal symptoms may occur 6-24 hours before the appearance of a lesion and include tingling, pain and/or itching in the perioral area.
- Cold sores are usually seen on the lips and extend to the skin around the mouth. Other areas on the face, chin, or nose are sometimes involved. Lesions begin as erythematous areas that swell into papules. These become vesicles, which then collapse into ulcers. This takes 1-3 days. The ulcers crust over and the skin returns to normal within about two weeks.
- Oral mucosal lesions are rare and not generally associated with fever. They are usually restricted to small clusters of microvesicles that rupture to leave punctate ulcers, typically on the palatal gingiva. Immunocompromised people may develop chronic ulcers, often on the tongue.
- Differential diagnosis of herpes simplex gingivostomatitis:
- Aphthous ulcers - do not cause fever; lesions are more likely to be on non-keratinised mucosa.
- Hand, foot and mouth disease - lesions may also be seen on the hands or feet.
- Herpes zoster of the second or third division of the trigeminal nerve.
- Infectious mononucleosis.
- Erythema multiforme.
- Stevens-Johnson syndrome.
- Behçet's disease.
- Differential diagnosis of cold sores:
- Signs of possible oral cancer include:
- Ulceration of the oral mucosa persisting for more than three weeks.
- Oral swellings persisting for more than three weeks.
- All red or red and white patches of the oral mucosa.
- The level of suspicion is further increased if the person is a heavy smoker, heavy alcohol drinker, aged over 45 years or male.
- The National Institute for Health and Care Excellence (NICE) guidance on referral for suspected cancer recommends urgent referral:
- By a doctor for unexplained ulceration in the oral cavity lasting for more than three weeks.
- By a dentist for:
- A lump on the lip or in the oral cavity consistent with oral cancer; or
- A red or red and white patch in the oral cavity consistent with erythroplakia or erythroleukoplakia.
- Tests are not usually necessary in immunocompetent people, as history and examination will usually confirm the diagnosis.
- Viral culture from swabs of lesions has been considered the gold standard but is limited by the short time period of viral shedding and the relatively low number of viral particles present in samples. Also, positives increase 48 hours after the lesions have appeared.
- Rapid detection based on polymerase chain reaction (PCR) is available when required (eg, immunocompromised patients, severe infection).
- Cold sores or gingivostomatitis are usually mild and self-limiting and so can be managed symptomatically. Reassure the patient that lesions will heal without scarring.
- A soft diet may be needed: drinking should also be encouraged to prevent dehydration.
- Give advice to reduce the risk of transmission:
- Avoid touching the lesions.
- Wash hands with soap and water immediately after touching the lesions, such as after applying medication.
- Topical medications should be dabbed on rather than rubbed in, to minimise trauma.
- Topical medications or other items that come into contact with a lesion area - eg, lipstick or lip gloss - should not be shared with others.
- Avoid kissing until the lesions have completely healed.
- Avoid oral sex until all lesions have completely healed.
- There is a risk of transmission to the eye if contact lenses become contaminated.
- Children with cold sores do not need to be excluded from nurseries and schools.
- Advise to seek medical advice if the person's condition deteriorates (eg, the lesion spreads, a new lesions develops after the initial outbreak, persistent fever, inability to eat) or no improvement is seen after 7-10 days.
- Paracetamol and ibuprofen are effective in relieving pain and pyrexia.
- Local analgesic for gingivostomatitis - benzydamine mouthwash (for those over 13 years) or spray (no age restriction but different doses above and below the age of 6).
- Chlorhexidine mouthwash for gingivostomatitis (age range not specified by the manufacturer).
- Choline salicylate gel for pain control of cold sores (this is contra-indicated under the age of 16 due to Reye's syndrome).
- Lidocaine gel for pain control of cold sores (there is no age restriction specified in the British National Formulary for Children).
- Topical antiviral agents:
- Aciclovir 5% (age range is not specified by the manufacturer).
- The benefits of topical antivirals are small and cold sores usually resolve within 7-10 days even without treatment.
- Topical antivirals do not prevent future episodes of cold sores alone but studies have found that a combination of 5% aciclovir and 1% hydrocortisone showed some preventative activity.
- Treatment needs to be initiated at the onset of symptoms before vesicles appear.
- Topical antivirals need to be applied frequently for a minimum of 4-5 days.
- Oral antiviral agents:
- For immunocompetent individuals, oral antivirals are not routinely indicated for the treatment of cold sores but may be indicated in severe episodes.
- Seek specialist advice for people who are immunocompromised (including people with HIV).
- Aciclovir is active against herpes viruses but does not eradicate them. It can be used as systemic and topical treatment of herpes simplex infections of the mucous membranes and is used orally for severe herpetic stomatitis.
- Valaciclovir is an ester of aciclovir. It is licensed for herpes simplex infections of the skin and mucous membranes.
- Inosine pranobex can be used for mucocutaneous herpes simplex but its efficacy remains unproven.
- The development of aciclovir resistance has led to the study of new antiviral targets, new antiviral mechanisms and new antiviral molecules from which it is hoped novel therapies will emerge.
- Intravenous antiviral agents:
- Foscarnet sodium is licensed for use in immunocompromised patients with mucocutaneous herpes simplex infection who do not respond to aciclovir.
Laser therapy decreases pain and reduces the number of recurrences. It is particularly useful for elderly patients, due to the low frequency of side-effects. However, large-scale double-blind trials have not yet been conducted.
- Seek advice for managing immunocompromised individuals who have cold sores, including people with HIV.
- Seek specialist advice if neonatal herpes is suspected (this is rare; it may present with skin, eye and/or mouth symptoms).
- Dehydration, especially in children.
- Recurrent lesions at the same site may occasionally cause atrophy and scarring.
- Secondary bacterial infection, including impetigo, can occur.
- Eczema herpeticum can complicate atopic eczema.
- Bell's palsy is possibly a complication of herpes simplex infection.
- Rare complications include dissemination, herpes encephalitis, meningitis, corneal dendritic ulcers (ocular herpes simplex) and erythema multiforme.
- Oral herpes simplex is usually a self-limiting disease.
- Lesions (whether due to primary infection or recurrent disease) usually heal within 7-10 days, without scarring.
- Sunscreen may be useful for people who have recurrences triggered by sunlight but the evidence is equivocal.
- A Cochrane review found evidence that long-term use of oral antivirals can prevent herpes simplex labialis, although the benefit is small. The review found no evidence to confirm the preventative efficacy of any other measures, including topical therapy and laser treatment.
Further reading and references
Vogel JL, Kristie TM; The dynamics of HCF-1 modulation of herpes simplex virus chromatin during initiation of infection. Viruses. 2013 May 225(5):1272-91. doi: 10.3390/v5051272.
Cunningham A, Griffiths P, Leone P, et al; Current management and recommendations for access to antiviral therapy of herpes labialis. J Clin Virol. 2012 Jan53(1):6-11. doi: 10.1016/j.jcv.2011.08.003. Epub 2011 Sep 1.
Kriesel JD, Bhatia A, Thomas A; Cold sore susceptibility gene-1 genotypes affect the expression of herpes labialis in unrelated human subjects. Hum Genome Var. 2014 Nov 201:14024. doi: 10.1038/hgv.2014.24. eCollection 2014.
Herpes simplex - oral; NICE CKS, October 2016 (UK access only)
Looker K et al; Global and Regional Estimates of Prevalent and Incident Herpes Simplex Virus Type 1 Infections in 2012, PLOS One, 2015.
Karjala Z, Neal D, Rohrer J; Association between HSV1 seropositivity and obesity: data from the National Health and Nutritional Examination Survey, 2007-2008. PLoS One. 2011 May 116(5):e19092. doi: 10.1371/journal.pone.0019092.
Suspected cancer: recognition and referral; NICE Clinical Guideline (2015 - last updated September 2020)
Kuypers J, Boughton G, Chung J, et al; Comparison of the Simplexa HSV1 & 2 Direct kit and laboratory-developed real-time PCR assays for herpes simplex virus detection. J Clin Virol. 2015 Jan62:103-5. doi: 10.1016/j.jcv.2014.11.003. Epub 2014 Nov 8.
British National Formulary (BNF); NICE Evidence Services (UK access only)
Aciclovir + hydrocortisone. Herpes labialis: a topical antiviral drug perhaps, but not a steroid; Prescrire Int. 2011 Sep20(119):205-7.
Jiang YC, Feng H, Lin YC, et al; New strategies against drug resistance to herpes simplex virus. Int J Oral Sci. 2016 Mar 308(1):1-6. doi: 10.1038/ijos.2016.3.
de Paula Eduardo C, Aranha AC, Simoes A, et al; Laser treatment of recurrent herpes labialis: a literature review. Lasers Med Sci. 2013 Apr 13.
Opstelten W, Neven AK, Eekhof J; Treatment and prevention of herpes labialis. Can Fam Physician. 2008 Dec54(12):1683-7.
Chi CC, Wang SH, Delamere FM, et al; Interventions for prevention of herpes simplex labialis (cold sores on the lips). Cochrane Database Syst Rev. 2015 Aug 7(8):CD010095. doi: 10.1002/14651858.CD010095.pub2.